Timothy Lu

Form D signer

Timothy Lu

Chief Executive Officer at Senti Biosciences

Form D signer

Capital raised by Senti Biosciences

$10.0M+$10.0M latest round

1 Form D filing · first filed May 2026 · South San Francisco, CA

CURRENT ROLE: Chief Executive Officer
SECTOR: Biotech
COMPANY FILINGS: 1
TEAM ON FILE: 2
FOUNDED: —
30D INTEREST: —

Career

1 company on file

Senti BiosciencesBiotech · South San Francisco, CAsince May 2026

Chief Executive Officer

Signatory on Senti Biosciences's Form D filings · $10.0M raised across 1

Company filings

via EDGAR · Form D for Senti Biosciences1

DateCompanyFormAmountRole on filing

May 20, 2026Senti BiosciencesForm D+$10.0MChief Executive Officer

Form DMay 20, 2026 · Senti Biosciences+$10.0Mas Chief Executive Officer

Overview

Last filing May 20, 2026

Timothy Lu is on file as Chief Executive Officer at Senti Biosciences in South San Francisco, CA. Senti Biosciences has 1 Form D filing on record, $10.0M raised in total. Timothy Lu appears as a signatory on the company's filings.

LinkedIn profile

Teammates

Senti Biosciences · 1

Kanya RajangamExecutive Officer

Products

Senti Biosciences · 1

Regulator Dial platformGenetic medicine platform

A proprietary technology platform integrating synthetic biology and AI to enable dynamic, post-administration control of genetic medicines, letting the expression of a delivered therapy be tuned after it is already in the patient. It is the company's go-forward focus following the July 2026 spin-out of the gene-circuit pipeline.